Skip to main content

Table 2 Bcl-2 immunoreactivity in ovarian tissue sections.

From: Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation

   % Positive Epithelium (n) % Positive Stroma (n)
  Total Total ≤ 50% > 50% Total ≤ 50% > 50%
Normal 2 50 (1) 100 (2) 0 100 (2) 0 100 (2)
Normal within Benign 5 100 (5) 100 (5) 0 --- --- ---
Normal within Cancer 4 100 (4) 50 (2) 50 (2) --- --- ---
Total Normal 11 91 (10) 82 (9) 18 (2) 100 (2) 0 100 (2)
Cysts 4 100 (4) 25 (1) 75 (3) 50 (2) 75 (3) 25 (1)
Cystadenomas 13 100 (13) 38 (5) 62 (8) 92 (12) 62 (8) 38 (5)
Total Benign 17 100 (17) 35 (6) 65 (11) 82 (14) 65 (11) 35 (6)
WD 3 100 (3) 33 (1) 67 (2) 100 (3) 66 (2) 33 (1)
MD 6 100 (6) 67 (4) 33 (2) 17 (1) 83 (5) 17 (1)
PD 19 68 (13) 79 (15) 21 (4) 68 (13) 95 (18) 5 (1)
Total Cancerous 28 79 (22) 71 (20) 29 (8) 61 (17) 89 (25) 11 (3)
  1. WD = well differentiated carcinoma, MD = moderately differentiated serous papillary carcinoma, PD = poorly differentiated serous papillary carcinoma